Ramil Abdrashitov
About Ramil Abdrashitov
Ramil Abdrashitov is the Senior Director of Clinical Development at BeiGene in Fulton, Maryland, with extensive experience at AstraZeneca and a strong academic background in finance and surgery.
Title
Ramil Abdrashitov holds the position of Senior Director of Clinical Development at BeiGene. He brings extensive experience to this role, currently based in Fulton, Maryland, United States.
Previous Experience at AstraZeneca
Ramil Abdrashitov worked at AstraZeneca from 2006 to 2021, a tenure spanning 15 years. During his time at AstraZeneca, he served as the Senior Global Development Medical Director in Gaithersburg, USA. He played a crucial role in several key initiatives, including representing AstraZeneca in the Risk-Based Monitoring group of the TransCelerate BioPharma consortium starting in 2012. He also spearheaded the implementation of Risk-Based Monitoring at the company in 2013 and led the Centralized Data Monitoring project.
Current Role at BeiGene
As the Senior Director of Clinical Development at BeiGene, Ramil Abdrashitov is responsible for overseeing significant aspects of clinical development processes. With his extensive background in clinical operations and development, he plays a pivotal role in advancing BeiGene's projects and clinical trials.
Education and Academic Background
Ramil Abdrashitov has a diverse academic background. He earned his MBA in Finance, General, from California State University - East Bay, completing the program in 2005-2006. Additionally, he holds a PhD in Surgery from the Perm State Medicine Academy named after E.A. Vagner (PSMA), reflecting his deep expertise in medical and clinical fields.
Clinical Operations Leadership
During his tenure at AstraZeneca, Ramil Abdrashitov oversaw clinical operations in Russia and Ukraine. His leadership was instrumental in significantly increasing their contributions to global clinical trials, enhancing the regions' roles in the company’s broader clinical research objectives.